EXPD vs ZYME · P/E 26, rev $10.60B vs rev $76.3M
Expeditors International of Washington, Inc. (EXPD) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Expeditors International of Washington, Inc. (EXPD) is a integrated freight & logistics company listed on NYSE.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported EXPD revenue for 2024-12-31 was $10.60B. Net income was $811.6M. Revenue was up 14.0% from 2023-12-31 to 2024-12-31. EXPD currently screens at market cap $21.01B and trailing P/E 26.0.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
EXPD currently screens at market cap $21.01B and trailing P/E 26.0. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the EXPD and ZYME stock pages for the full models.
Not investment advice.